# Oxford Pre-cancerous Lymphoproliferative Disorders Study

> **NCT04023747** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Oxford** · enrollment: 574 (actual)

## Conditions studied

- Pre-cancerous Lymphoproliferative Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04023747
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-03
- **Primary completion:** 2025-10
- **Final completion:** 2025-10
- **Target enrollment:** 574 (ACTUAL)
- **Last updated:** 2025-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04023747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04023747, "Oxford Pre-cancerous Lymphoproliferative Disorders Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04023747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*